ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CRY CryoLife Inc

17.88
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
CryoLife Inc NYSE:CRY NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 17.88 0 01:00:00

Statement of Changes in Beneficial Ownership (4)

09/03/2020 8:11pm

Edgar (US Regulatory)


FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Holloway Jean F
2. Issuer Name and Ticker or Trading Symbol

CRYOLIFE INC [ CRY ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
VP, General Counsel
(Last)          (First)          (Middle)

1655 ROBERTS BLVD., NW
3. Date of Earliest Transaction (MM/DD/YYYY)

3/5/2020
(Street)

KENNESAW, GA 30144
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 3/5/2020 3/5/2020 A  4084 (1)A$0 69503 D  
Common Stock 3/5/2020 3/5/2020 F  615 (2)D$24.93 68888 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) Represents performance stock units granted on March 5, 2019 and earned at approximately 82.5% of target based on 2019 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2020. The remaining shares earned in connection with the March 2019 grant will vest and be issued as follows: 25% on 03/05/2021, and 25% on 03/5/2022, assuming continued employment on the relevant vesting date.
(2) These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Holloway Jean F
1655 ROBERTS BLVD., NW
KENNESAW, GA 30144


VP, General Counsel

Signatures
/s/ Jean F Holloway3/9/2020
**Signature of Reporting PersonDate

1 Year CryoLife Chart

1 Year CryoLife Chart

1 Month CryoLife Chart

1 Month CryoLife Chart

Your Recent History

Delayed Upgrade Clock